Avadel Pharmaceuticals plc (AVDL)
NASDAQ: AVDL · Real-Time Price · USD
9.59
+0.20 (2.13%)
At close: May 12, 2025, 4:00 PM
9.63
+0.04 (0.42%)
After-hours: May 12, 2025, 7:25 PM EDT
Avadel Pharmaceuticals Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Avadel Pharmaceuticals stock have an average target of 18.86, with a low estimate of 12 and a high estimate of 30. The average target predicts an increase of 96.66% from the current stock price of 9.59.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Avadel Pharmaceuticals stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 5 | 5 | 5 | 5 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +98.12% | May 8, 2025 |
| Needham | Needham | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +98.12% | Apr 9, 2025 |
| Needham | Needham | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +98.12% | Mar 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $21 | Strong Buy | Reiterates | $21 | +118.98% | Mar 4, 2025 |
| Needham | Needham | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +98.12% | Mar 3, 2025 |
Financial Forecast
Revenue This Year
254.57M
from 169.12M
Increased by 50.53%
Revenue Next Year
336.88M
from 254.57M
Increased by 32.33%
EPS This Year
0.09
from -0.51
EPS Next Year
0.76
from 0.09
Increased by 709.42%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 267.5M | 386.9M | 463.3M | ||
| Avg | 254.6M | 336.9M | 404.1M | ||
| Low | 235.7M | 270.7M | 318.2M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 58.1% | 52.0% | 37.5% | ||
| Avg | 50.5% | 32.3% | 19.9% | ||
| Low | 39.4% | 6.3% | -5.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.18 | 1.06 | 2.13 |
| Avg | 0.09 | 0.76 | 1.37 |
| Low | -0.03 | 0.22 | 0.46 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 1,034.7% | 181.8% |
| Avg | - | 709.4% | 80.4% |
| Low | - | 130.7% | -39.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.